CPEX Pharmaceuticals, Inc. CPEX today confirmed that it has received an unsolicited, non-binding letter from Mangrove Partners regarding a potential alternative transaction involving a recapitalization of CPEX.
CPEX has also said that its Board of Directors will review the terms of the Mangrove Letter as soon as practicable in a manner consistent with its duties and the merger agreement with FCB I Holdings Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in